4.4 Legal risk - Scor
4.4 Legal risk - Scor
4.4 Legal risk - Scor
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
B. Life reinsurance<br />
The main categories of <strong>risk</strong>s for the life reinsurance underwritten by SCOR’s Life division, which is referred to in this<br />
Registration document as “SCOR Global Life,” “Life” or its “Life division,” are biometric, behavioral and catastrophe <strong>risk</strong>s<br />
as well as credit <strong>risk</strong> (see “Section 4.1.14 - SCOR is exposed to losses due to counterparty default <strong>risk</strong>s or credit <strong>risk</strong>s”),<br />
currency <strong>risk</strong>s (see “Section 4.2.4 – SCOR is exposed to foreign currency exchange rate fluctuations”) and market <strong>risk</strong>s<br />
(see “Section 4.2 – Market <strong>risk</strong>” and “Section 4.2.3 – SCOR is exposed to other <strong>risk</strong>s arising from the instruments it<br />
owns”).<br />
(a) Biometric <strong>risk</strong>s<br />
The assessment of biometric <strong>risk</strong>s is at the centre of underwriting in life reinsurance. These are <strong>risk</strong>s which result from<br />
adverse developments in mortality, morbidity, longevity or from epidemic/pandemic claims. These <strong>risk</strong>s are evaluated by<br />
the actuaries, research centers and medical underwriters of SCOR Global Life, who analyze and use information from<br />
SCOR Global Life’s own portfolio experience, from the ceding companies as well as relevant information available in the<br />
public domain, such as mortality or disability studies and tables as available from various sources, e.g. actuarial<br />
associations or medical research bodies.<br />
Mortality Risk<br />
Mortality <strong>risk</strong> is the <strong>risk</strong> of negative deviation from expected results due to higher than anticipated death rates resulting<br />
from either the inherent volatility, an adverse long-term trend or a mortality shock event in the reinsured portfolio.<br />
Morbidity Risk<br />
Products such as critical illness, short-term and long-term disability and long term care, which all contain morbidity <strong>risk</strong>,<br />
are subject to the <strong>risk</strong> of negative trends in health, as well as to the consequences of improved medical diagnoses<br />
capabilities which increase the number of claims that otherwise would possibly have remained undetected. Medical<br />
progress may enable better treatment resulting in higher claims since certain diseases would have otherwise led to<br />
immediate death of insureds. Products providing cover for medical expenses are in particular subject to the <strong>risk</strong> of higher<br />
than frequency incidence rates and inflation of medical costs.<br />
Longevity Risk<br />
Longevity <strong>risk</strong> refers to the <strong>risk</strong> of a negative deviation from expected results due to the insured or annuitant living longer<br />
than assumed in the pricing of the insurance cover. This <strong>risk</strong> exists within annuity and long-term care covers and within<br />
other longevity protection products.<br />
Pandemic<br />
In Life reinsurance, a severe pandemic is a major <strong>risk</strong>. In the past century, three major outbreaks of influenza occurred<br />
and claimed millions of lives. The occurrence of a similar event could cause large losses to SCOR due to an increased<br />
mortality far beyond the usual volatility. Experts closely monitor current influenza virus strains and those of other<br />
infectious diseases. A lethal virus strain not only of influenza but of any other communicable disease could lead to a<br />
heavy increase in mortality rates and increased medical costs which could significantly affect SCOR’s results.<br />
The potential loss relating to a severe pandemic is estimated using models. However, the limited amount of available<br />
historical data, combined with the generic model <strong>risk</strong>, creates a high degree of uncertainty in the results. The financial<br />
outcome of a severe pandemic could, therefore, differ considerably from that expected by the model, thus leading to a<br />
potentially significantly higher loss than expected.<br />
(b) Behavioural <strong>risk</strong>s<br />
SCOR Global Life is also exposed to <strong>risk</strong>s related to policyholder behaviour. This includes <strong>risk</strong>s such as lapsation, antiselection<br />
at policy issue, resale of policies, exercising of policy options by the policyholder different from expected, and<br />
fraudulent applications.<br />
Lapsation<br />
Lapses refer to either non-payment of premium by the policyholder or to policies which are terminated by the<br />
policyholder before the maturity date of the policy. Depending upon the product design, higher or lower policyholder<br />
lapses than assumed in the pricing may reduce SCOR Global Life’s expected future income. Policyholder lapses may<br />
differ from expectations due to a changing economic environment or other reasons, such as changes in tax incentives<br />
for the insurance policies, tarnished reputation of the cedant or from the introduction of more attractive insurance<br />
products in the market. SCOR studies and closely monitors this <strong>risk</strong>.<br />
Anti-selection<br />
Anti-selection refers to the problem of asymmetry of information between the insured and the insurer. An individual<br />
applying for life or health insurance cover usually has better knowledge about his or her own state of health than the<br />
insurer. The <strong>risk</strong> to the (re)insurer is of policyholders deliberately deciding among other things to:<br />
• take out a policy in the knowledge that either their chances of claiming is high or higher than average;<br />
• terminate a policy in the knowledge that their chances of claiming are low or lower than average; or<br />
22